Epidemiology and clinical characteristics of parainfluenza virus 3 outbreak in a Haemato-oncology unit

Journal of Infection

Volumn 65, Issue 3, 2012, Pages 246-254

  Harvala, Heli ^a   Gaunt, Eleanor ^b   McIntyre, Chloe ^c   Roddie, Huw ^d   Labonte, Sharon ^d   Curran, Evonne ^e   Othieno, Richard ^f   Simmonds, Peter ^c   Bremner, John ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

^e HEALTH PROTECTION SCOTLAND   (United Kingdom)

^f NHS LOTHIAN   (United Kingdom)

Author keywords

Haematology; Hospital; Infection control; Outbreak; Parainfluenza virus type 3; PIV3; Virus

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CANCER RELAPSE; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDEMIC; FEMALE; FEVER; GENE SEQUENCE; GENERAL HOSPITAL; HEMAGGLUTININ GENE; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION CONTROL; LOWER RESPIRATORY TRACT INFECTION; MALE; MIXED INFECTION; MOLECULAR EPIDEMIOLOGY; MORTALITY; PARAINFLUENZA VIRUS 3; PARAINFLUENZA VIRUS INFECTION; RETROSPECTIVE STUDY; UPPER RESPIRATORY TRACT INFECTION; VIRUS GENE; VIRUS TRANSMISSION;

ADULT; AGED; AGED, 80 AND OVER; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; HOSPITAL DEPARTMENTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PARAINFLUENZA VIRUS 3, HUMAN; PHYLOGENY; RESPIROVIRUS INFECTIONS; RETROSPECTIVE STUDIES; SCOTLAND;

EID: 84864538123     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.04.011     Document Type: Article

References (30)

1. Laurichesse H., Dedman D., Watson J.M., Zambon M.C. Epidemiological features of parainfluenza virus infections: laboratory surveillance in England and Wales, 1975-1997. Eur J Epidemiol 1999, 15:475-484.
2. Hall C.B. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001, 344:1917-1928.
3. Sable C.A., Hayden F.G. Orthomyxoviral and paramyxoviral infections in transplant patients. Infect Dis Clin North Am 1995, 9:987-1003.
4. Whimbey E., Vartivarian S.E., Champlin R.E., Elting L.S., Luna M., Bodey G.P. Parainfluenza virus infection in adult bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis 1993, 12:699-701.
5. Elizaga J., Olavarria E., Apperley J., Goldman J., Ward K. Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment. Clin Infect Dis 2001, 32:413-418.
6. Swierkosz E.M., Erdman D.D., Bonnot T., Schneiderheinze C., Waner J.L. Isolation and characterization of a naturally occurring parainfluenza 3 virus variant. J Clin Microbiol 1995, 33:1839-1841.
7. Jalal H., Bibby D.F., Bennett J., Sampson R.E., Brink N.S., MacKinnon S., et al. Molecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unit. J Clin Microbiol 2007, 45:1690-1696.
8. Hodson A., Kasliwal M., Streetly M., Macmahon E., Raj K. A parainfluenza-3 outbreak in a SCT unit: sepsis with multi-organ failure and multiple co-pathogens are associated with increased mortality. Bone Marrow Transplant 2011.
9. Lewis V.A., Champlin R., Englund J., Couch R., Goodrich J.M., Rolston K., et al. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin Infect Dis 1996, 23:1033-1037.
10. Cobian L., Houston S., Greene J., Sinnott J.T. Parainfluenza virus respiratory infection after heart transplantation: successful treatment with ribavirin. Clin Infect Dis 1995, 21:1040-1041.
11. Zambon M., Bull T., Sadler C.J., Goldman J.M., Ward K.N. Molecular epidemiology of two consecutive outbreaks of parainfluenza 3 in a bone marrow transplant unit. J Clin Microbiol 1998, 36:2289-2293.
12. Cortez K.J., Erdman D.D., Peret T.C., Gill V.J., Childs R., Barrett A.J., et al. Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population. J Infect Dis 2001, 184:1093-1097.
13. Nichols W.G., Erdman D.D., Han A., Zukerman C., Corey L., Boeckh M. Prolonged outbreak of human parainfluenza virus 3 infection in a stem cell transplant outpatient department: insights from molecular epidemiologic analysis. Biol Blood Marrow Transplant 2004, 10:58-64.
14. Maziarz R.T., Sridharan P., Slater S., Meyers G., Post M., Erdman D.D., et al. Control of an outbreak of human parainfluenza virus 3 in hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2010, 16:192-198.
15. Hohenthal U., Nikoskelainen J., Vainionpaa R., Peltonen R., Routamaa M., Itala M., et al. Parainfluenza virus type 3 infections in a hematology unit. Bone Marrow Transplant 2001, 27:295-300.
16. Lee A.V., Bibby D.F., Oakervee H., Rohatiner A., Ushiro-Lumb I., Clark D.A., et al. Nosocomial transmission of parainfluenza 3 virus in hematological patients characterized by molecular epidemiology. Transpl Infect Dis 2011, 13:433-437.
17. Piralla A., Percivalle E., Cesare-Merlone A., Locatelli F., Gerna G. Multicluster nosocomial outbreak of parainfluenza virus type 3 infection in a pediatric oncohematology unit: a phylogenetic study. Haematologica 2009, 94:833-839.
18. Karron R.A., Froehlich J.L., Bobo L., Belshe R.B., Yolken R.H. Rapid detection of parainfluenza virus type 3 RNA in respiratory specimens: use of reverse transcription-PCR-enzyme immunoassay. J Clin Microbiol 1994, 32:484-488.
19. Wyke Coelingh K.L., Winter C.C., Murphy B.R. Nucleotide and deduced amino acid sequence of hemagglutinin-neuraminidase genes of human type 3 parainfluenza viruses isolated from 1957 to 1983. Virology 1988, 162:137-143.
20. Echevarria J.E., Erdman D.D., Meissner H.C., Anderson L. Rapid molecular epidemiologic studies of human parainfluenza viruses based on direct sequencing of amplified DNA from a multiplex RT-PCR assay. J Virol Methods 2000, 88:105-109.
21. Templeton K.E., Bredius R.G., Scheltinga S.A., Claas E.C., Vossen J.M., Kroes A.C. Parainfluenza virus 3 infection pre- and post-haematopoietic stem cell transplantation: re-infection or persistence?. J Clin Virol 2004, 29:320-322.
22. Ljungman P., Gleaves C.A., Meyers J.D. Respiratory virus infection in immunocompromised patients. Bone Marrow Transplant 1989, 4:35-40.
23. Kapikian A.Z., Chanock R.M., Reichelderfer T.E., Ward T.G., Huebner R.J., Bell J.A. Inoculation of human volunteers with parainfluenza virus type 3. JAMA 1961, 178:537-541.
24. Muchmore H.G., Parkinson A.J., Humphries J.E., Scott E.N., McIntosh D.A., Scott L.V., et al. Persistent parainfluenza virus shedding during isolation at the South Pole. Nature 1981, 289:187-189.
25. Jeffries D.J. Viral hazards to and from health care workers. J Hosp Infect 1995, 30(Suppl.):140-155.
26. Maltezou H.C., Drancourt M. Nosocomial influenza in children. J Hosp Infect 2003, 55:83-91.
27. Wendt C.H., Weisdorf D.J., Jordan M.C., Balfour H.H., Hertz M.I. Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med 1992, 326:921-926.
28. Schiffer J.T., Kirby K., Sandmaier B., Storb R., Corey L., Boeckh M. Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation. Haematologica 2009, 94:1101-1108.
29. Avadhanula V., Rodriguez C.A., Devincenzo J.P., Wang Y., Webby R.J., Ulett G.C., et al. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J Virol 2006, 80:1629-1636.
30. Nichols W.G., Corey L., Gooley T., Davis C., Boeckh M. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 2001, 98:573-578.